key clinical trials investigating immunotherapy in her2 and hr breast cancer
Published 2 years ago • 757 plays • Length 6:54Download video MP4
Download video MP3
Similar videos
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
2:05
immunotherapy in breast cancer
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
0:56
gut microbiome and treatment outcomes in hr /her2- breast cancer
-
0:47
limitations and potential of phase ii patricia trial in her2 /hr advanced breast cancer
-
1:00
utilizing neoadjuvant immunotherapies in patients with er , her2- primary breast cancer
-
3:10
genomic profiling of hr /her2- breast cancer and brain metastases
-
0:34
future role of immunotherapy in her2 breast cancer
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
1:11:09
the emergence of immunosuppressive myeloid cells in breast cance, kai kessenbrock, phd | uci
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
2:56
key clinical trials in breast cancer presented at sabcs 2021
-
4:52
3-year dfs in randomized trials of chemotherapy and her2-targeted therapy
-
0:36
maintenance w/ et ribociclib after 1l chemotherapy in hr /her2- metastatic breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
1:33
dr. rimawi on the clinical need for immunotherapy in her2-positive breast cancer
-
0:57
neohip: neoadjuvant her2-targeted therapy /- io with pembrolizumab
-
1:17
key trial updates in serds in er /her2- breast cancer from sabcs 2022
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
2:15
treatment strategies for her2 metastatic breast cancer
-
1:06
immunotherapy combination in her2-positive breast cancer